The effect of angiotensin converting enzyme inhibitor versus angiotensin receptor blocker therapy on endothelial function of diabetic patients without overt cardiovascular disease; a comparative study

被引：0
|
作者：
Symeonides, P.
Vratsista, E.
Triantafyllou, K.
Koulouris, S.
机构：
[1] Evangelismos Med Ctr, Athens, Greece
[2] Nicosia Gen Hosp, Nicosia, Cyprus
来源：
EUROPEAN HEART JOURNAL | 2006年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：496 / 496
页数：1
相关论文
共 50 条
  • [31] Beneficial effect of combination therapy with an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor on overt proteinuria in a patient with type 1 diabetic nephropathy
    Kuriyama, S
    Tomonari, H
    Abe, A
    Imasawa, T
    Hosoya, T
    NEPHRON, 2000, 86 (04): : 529 - 530
  • [32] Combined angiotensin converting enzyme inhibitor/angiotensin receptor blocker (ACEI/ARB) therapy is safe and effective in kidney transplant patients
    Reilly, James B.
    Goral, Simin
    Bloom, Roy D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 533 - 533
  • [33] The effects of angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, and it's combination therapies on development of diabetic nephropathy
    Sen, Saniye
    Ustundag, Sedat
    Gonlusen, Gulfiliz
    Kanter, Mehmet
    Dogutan, Haluk
    Ciftci, Senturk
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 53 - 53
  • [34] Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
    Rossato, Marco
    Di Vincenzo, Angelo
    EUROPEAN CARDIOLOGY REVIEW, 2020, 15
  • [35] Kidney Outcomes Following Angiotensin Receptor-Neprilysin Inhibitor vs Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy for Thrombotic Microangiopathy
    Li, Jianbo
    Liu, Qinghua
    Lian, Xingji
    Yang, Shicong
    Lian, Rong
    Li, Wenchuan
    Yu, Jianwen
    Huang, Fengxian
    Chen, Wenfang
    He, Feng
    Chen, Wei
    JAMA NETWORK OPEN, 2024, 7 (09)
  • [36] A CLINICAL EVALUATION OF HYPERKALAEMIA IN PATIENTS WITH RENAL IMPAIRMENT ON COMBINATION THERAPY OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND ANGIOTENSIN-RECEPTOR BLOCKER
    Goh, T. H.
    Tan, S. C.
    Fook-Chong, S. M. C.
    Wong, K. S.
    Chan, C. M.
    NEPHROLOGY, 2005, 10 : A139 - A139
  • [37] The Efficacy of Angiotensin Receptor-Neprilysin Inhibitor Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Post Myocardial Infarction: A Meta-Analysis
    Kotak, Sohny
    Hassan, Warda
    Mehmood, Marium
    Kumar, Umesh
    Sagreeka, Fnu
    Karishma, Fnu
    Kumari, Pirya
    Pirya, Fnu
    Saquib, Javeria
    Iqbal, Amna
    Khan, Anosh Aslam
    Varrassi, Giustino
    Khatri, Mahima
    Kumar, Satesh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [38] Proteinuria, Chronic Kidney Disease, and the Effect of an Angiotensin Receptor Blocker in Addition to an Angiotensin-Converting Enzyme Inhibitor in Patients With Moderate to Severe Heart Failure
    Anand, Inder S.
    Bishu, Kalkidan
    Rector, Thomas S.
    Ishani, Areef
    Kuskowski, Michael A.
    Cohn, Jay N.
    CIRCULATION, 2009, 120 (16) : 1577 - 1584
  • [39] THE EFFECT OF COMBINED ANGIOTENSIN CONVERTING ENZYME INHIBITOR (ACE-I) AND ANGIOTENSIN II RECEPTOR BLOCKER (ARB) ON ANAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Yang, W. S.
    Fook-Chong, S. M. C.
    Wong, K. S.
    Chan, C. M.
    NEPHROLOGY, 2005, 10 : A139 - A140
  • [40] Rationale for the use of combination angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy in heart failure
    Carson, PE
    AMERICAN HEART JOURNAL, 2000, 140 (03) : 361 - 366
12345